Ahmed A. Shaaban

650 total citations
31 papers, 497 citations indexed

About

Ahmed A. Shaaban is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Ahmed A. Shaaban has authored 31 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Pharmacology. Recurrent topics in Ahmed A. Shaaban's work include Chemotherapy-induced organ toxicity mitigation (5 papers), Liver physiology and pathology (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Ahmed A. Shaaban is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (5 papers), Liver physiology and pathology (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Ahmed A. Shaaban collaborates with scholars based in Egypt, Saudi Arabia and United States. Ahmed A. Shaaban's co-authors include Dina S. El‐Agamy, Dalia H. El‐Kashef, Mohamed A. Elkablawy, Mohamed F. Hamed, Mohamed E. Shaker, Hany M. Abo‐Haded, Farid A. Badria, Elham Abdelmonem Mohamed, Irhan Ibrahim Abu Hashim and Tarek M. Ibrahim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Life Sciences.

In The Last Decade

Ahmed A. Shaaban

29 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed A. Shaaban Egypt 14 173 83 80 69 68 31 497
Xudong Hu China 17 253 1.5× 153 1.8× 121 1.5× 73 1.1× 57 0.8× 44 663
Jooyoung Lee South Korea 16 246 1.4× 84 1.0× 53 0.7× 49 0.7× 26 0.4× 24 628
Adel G. Bakr Egypt 10 131 0.8× 42 0.5× 87 1.1× 42 0.6× 36 0.5× 18 378
Gehan A. Hegazy Saudi Arabia 11 140 0.8× 63 0.8× 70 0.9× 33 0.5× 34 0.5× 31 500
Bingbing Zhu China 14 238 1.4× 82 1.0× 44 0.6× 53 0.8× 21 0.3× 50 609
Xiaohan Zhai China 16 362 2.1× 142 1.7× 101 1.3× 61 0.9× 21 0.3× 31 745
Hongyang Liu China 14 189 1.1× 87 1.0× 32 0.4× 95 1.4× 29 0.4× 37 528
Sara Mohamed Naguib Abdel Hafez Egypt 14 141 0.8× 32 0.4× 70 0.9× 21 0.3× 37 0.5× 54 527
Paloma Gallego Spain 12 272 1.6× 314 3.8× 59 0.7× 119 1.7× 74 1.1× 14 666
Kezhen Shen China 14 195 1.1× 162 2.0× 58 0.7× 82 1.2× 50 0.7× 18 777

Countries citing papers authored by Ahmed A. Shaaban

Since Specialization
Citations

This map shows the geographic impact of Ahmed A. Shaaban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed A. Shaaban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed A. Shaaban more than expected).

Fields of papers citing papers by Ahmed A. Shaaban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed A. Shaaban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed A. Shaaban. The network helps show where Ahmed A. Shaaban may publish in the future.

Co-authorship network of co-authors of Ahmed A. Shaaban

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed A. Shaaban. A scholar is included among the top collaborators of Ahmed A. Shaaban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed A. Shaaban. Ahmed A. Shaaban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaaban, Ahmed A., et al.. (2024). Biological effective dose as a predictor of local tumor control in stereotactic radiosurgery treated parasellar meningioma patients. Journal of Neuro-Oncology. 170(2). 377–385. 1 indexed citations
2.
Ahmed, Hala, et al.. (2024). G protein-coupled estrogen receptor selective agonist, G1, improves the molecular and biochemical markers in a cisplatin mouse model of CKD. Chemico-Biological Interactions. 398. 111065–111065. 1 indexed citations
3.
4.
5.
6.
Shaker, Mohamed E., et al.. (2023). Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib. Frontiers in Pharmacology. 14. 1212771–1212771. 2 indexed citations
7.
El-Baz, Ahmed M., et al.. (2023). Formulation and microbiological ancillary studies of gemifloxacin proniosomes for exploiting its role against LPS acute pneumonia model. Journal of Drug Delivery Science and Technology. 81. 104053–104053. 3 indexed citations
8.
Shaker, Mohamed E., et al.. (2023). Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunities. International Immunopharmacology. 120. 110373–110373. 3 indexed citations
9.
Saleh, Mohamed A., Ahmed A. Shaaban, Iman M. Talaat, et al.. (2023). RhoA/ROCK inhibition attenuates endothelin-1–induced glomerulopathy in the rats. Life Sciences. 323. 121687–121687. 5 indexed citations
10.
Shata, Ahmed, Ahmed A. Shaaban, Sameh Saber, et al.. (2022). The Effects of Hyphaena thebaica and Lactobacillus in Dextran Sodium Sulphate-Induced Ulcerative Colitis in Rats. 5(2). 201–213. 1 indexed citations
11.
Shaaban, Ahmed A., A. M. Abdelhamid, Simona Cavalu, et al.. (2022). Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis. Biomedicine & Pharmacotherapy. 153. 113247–113247. 19 indexed citations
12.
Shaker, Mohamed E., Mohamed F. Hamed, & Ahmed A. Shaaban. (2022). Digoxin mitigates diethylnitrosamine-induced acute liver injury in mice via limiting production of inflammatory mediators. Saudi Pharmaceutical Journal. 30(3). 291–299. 7 indexed citations
13.
Sharawy, Maha H., Dalia H. El‐Kashef, Ahmed A. Shaaban, & Dina S. El‐Agamy. (2021). Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-κB inhibition. International Immunopharmacology. 100. 108088–108088. 18 indexed citations
14.
Shaker, Mohamed E., Ahmed A. Shaaban, Mohamed El‐Shafey, & Mohamed El‐Mesery. (2020). The selective c-Met inhibitor capmatinib offsets cisplatin-nephrotoxicity and doxorubicin-cardiotoxicity and improves their anticancer efficacies. Toxicology and Applied Pharmacology. 398. 115018–115018. 17 indexed citations
15.
Shaker, Mohamed E., et al.. (2020). The c-Met inhibitor capmatinib alleviates acetaminophen-induced hepatotoxicity. International Immunopharmacology. 81. 106292–106292. 16 indexed citations
16.
Shaaban, Ahmed A., et al.. (2019). Thoracic spinal intramedullary arachnoid cyst presented with myelopathy with marked postoperative improvement: A case report and review of literature. Asian Journal of Neurosurgery. 14(3). 981–984. 3 indexed citations
17.
Mohamed, Elham Abdelmonem, Irhan Ibrahim Abu Hashim, Ahmed A. Shaaban, et al.. (2018). Polymeric micelles for potentiated antiulcer and anticancer activities of naringin. International Journal of Nanomedicine. Volume 13. 1009–1027. 60 indexed citations
18.
Shebl, Abdelhadi M., et al.. (2017). Modulation of d-galactosamine/lipopolysacharride–induced fulminant hepatic failure by nilotinib. Human & Experimental Toxicology. 37(1). 51–60. 6 indexed citations
19.
Shaaban, Ahmed A., et al.. (2013). Effect of Taurine on The Respiratory System of Rats. SHILAP Revista de lepidopterología. 1(2). 1 indexed citations
20.
Shaaban, Ahmed A., Mohamed E. Shaker, Khaled Zalata, Hassan A. El‐Kashef, & Tarek M. Ibrahim. (2013). Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3. Chemico-Biological Interactions. 207. 81–91. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xudong Hu Breakdown of academic impact, for papers by Jooyoung Lee Breakdown of academic impact, for papers by Adel G. Bakr Breakdown of academic impact, for papers by Gehan A. Hegazy Breakdown of academic impact, for papers by Bingbing Zhu Breakdown of academic impact, for papers by Xiaohan Zhai Breakdown of academic impact, for papers by Hongyang Liu Breakdown of academic impact, for papers by Sara Mohamed Naguib Abdel Hafez Breakdown of academic impact, for papers by Paloma Gallego Breakdown of academic impact, for papers by Kezhen Shen
Rankless by CCL
2026